Karyopharm Therapeutics Inc.

Attention US HCPs: Karyopharm strives to provide accurate and timely medical information, the latest congress and publications information to our US HCPs about our products and disease areas of interest. If you want more information visit the Karyopharm Global Medical and Scientific Affairs Website that has been developed to keep you abreast of our latest research. #MultipleMyeloma #Myelofibrosis #EndometrialCancer #BelieversInTheExtraordinary

In celebration of Women's History Month, we proudly share our commitment to supporting women at KPTI. Their boundless impact on our ability to deliver for patients is truly remarkable. We are honored to hear from them about their experiences and advice on thriving as women in biotech.

On #InternationalWomensDay, we would like to shine a spotlight on?Jenny Myers Ahlstrom, a #multiplemyeloma patient who was determined to harness the collective power of patient experiences to help people with blood cancer learn more about their disease and better navigate their care. In 2012, she founded the HealthTree Foundation to do just that. Learn more about this organization:?https://bit.ly/41grx53?#BelieversInTheExtraordinary

March is Multiple Myeloma Action Month! This year's theme, #MyelomaMilestone, is empowering individuals to share their personal milestones in the fight against #multiplemyeloma. We're proud to partner with the?International Myeloma Foundation?in its mission to amplify patient voices. Learn more about this initiative:?https://bit.ly/3XwjAHU

Congratulations to our 2025 Q1 ICARE award winners who exemplify our company values: Innovation, Courage, Alignment & Accountability, and Energy.??Karyopharm's ICARE values drive our mission to pioneer novel cancer treatment and improve patient outcomes.?We are committed to fostering a culture of collaboration and excellence, empowering our teams to challenge the status quo and deliver groundbreaking therapies.?Cynthia Brasher Bhargavi Pandit RPh, MS, RAC Kai Li, Ph.D in Statistics Danielle Miller Christine E. Lentowski M.S. M.B.A. #EmployeeAppreciationDay

Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress. Learn more here: https://bit.ly/3Qmlo2b

Introducing our new Talent Community! Not ready to apply? Not seeing a job that matches your interests? Join our Talent Community to stay connected.?By signing up, you’ll gain access to updates about career opportunities, company news, and information tailored to your professional interests. Whether you are exploring future roles or simply would like to stay informed, our Talent Community keeps you informed and inspired. Connect with us today! https://lnkd.in/ezb6h6dT

Karyopharm to report fourth quarter and full year 2024 financial results and recent company progress on Wednesday, February 19. Tune in to the webcast at 8 A.M. ET. Learn more here: https://bit.ly/3CVHQvK

We're proud to support the?Union for International Cancer Control (UICC)?in its #WorldCancerDay campaign, #UnitedByUnique, which highlights the importance of people-centered approaches to?cancer?and the unique needs of each patient. Learn more about this initiative and the UICC:?https://bit.ly/40V8qi3?#BelieversInTheExtraordinary

#MultipleMyeloma disproportionately affects African Americans?and many may face delayed diagnosis.?In recognition of this and in honor of #BlackHistoryMonth, we shine a spotlight on the important work that the International Myeloma Foundation is doing to raise awareness through its M-Power program.?To learn more, please visit?https://lnkd.in/gZQ5WtJ?#BelieversInTheExtraordinary